Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,798 | 4,165 | 4,727 | 9,046 | 22,138 |
| Other current assets | 0 | 0 | 0 | 0 | 5,073 |
| TOTAL | $2,235 | $4,454 | $8,633 | $9,447 | $27,350 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,500 | 0 | 0 | 0 | 0 |
| TOTAL | $1,500 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,735 | $4,454 | $8,633 | $9,447 | $27,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 194 | 132 | 89 | 348 | 16,912 |
| Accrued Expenses | 2,750 | 4 | 4 | 6 | 24 |
| TOTAL | $2,989 | $181 | $139 | $399 | $17,281 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,989 | $181 | $139 | $399 | $17,281 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,179 | N/A | 36,376 | 36,611 | 35,201 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -22,877 | -19,500 | -15,549 | -15,080 | -14,059 |
| Other shareholders' equity | 495 | -354 | -84 | 0 | 0 |
| TOTAL | $746 | $4,274 | $8,495 | $9,049 | $10,069 |
| Total Liabilities And Equity | $3,735 | $4,454 | $8,633 | $9,447 | $27,350 |